Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Change in Cash (2017 - 2025)

Neuronetics (STIM) has disclosed Change in Cash for 9 consecutive years, with $17.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Cash rose 178.08% to $17.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $13.6 million, a 190.81% increase, with the full-year FY2024 number at -$40.2 million, down 277.17% from a year prior.
  • Change in Cash was $17.0 million for Q3 2025 at Neuronetics, up from -$3.8 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $72.3 million in Q1 2021 to a low of -$21.8 million in Q3 2024.
  • A 5-year average of -$762421.1 and a median of -$5.3 million in 2021 define the central range for Change in Cash.
  • Biggest YoY gain for Change in Cash was 809.65% in 2023; the steepest drop was 463.5% in 2023.
  • Neuronetics' Change in Cash stood at -$5.3 million in 2021, then skyrocketed by 36.56% to -$3.4 million in 2022, then surged by 809.65% to $23.8 million in 2023, then plummeted by 105.91% to -$1.4 million in 2024, then surged by 1307.53% to $17.0 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Change in Cash are $17.0 million (Q3 2025), -$3.8 million (Q2 2025), and $1.8 million (Q1 2025).